Ustekinumab Market By Indication (Psoriasis {Plaque Psoriasis, Erythrodermic Psoriasis, Guttate Psoriasis}, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis, Other Autoimmune Disorders), By Dosage Form (Pre-filled Syringes, Vials, Auto-injectors), By Route of Administration (Subcutaneous Injection, Intravenous Infusion), By Strength (45 mg, 90 mg, 130 mg), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Country Analysis (U.S., Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, Brazil, Argentina, Mexico, Saudi Arabia, UAE, South Africa), Company share analysis And Market Forecast

Report Coverage:

By Indication

• Psoriasis
  • Plaque Psoriasis
  • Erythrodermic Psoriasis
  • Guttate Psoriasis
• Psoriatic Arthritis
• Crohn’s Disease
• Ulcerative Colitis
• Other Autoimmune Disorders

By Dosage Form

• Pre-filled Syringes
• Vials
• Auto-injectors

By Route of Administration

• Subcutaneous Injection
• Intravenous Infusion

By Strength

• 45 mg
• 90 mg
• 130 mg

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

By Region

North America

• The U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea

Latin America

• Brazil
• Argentina
• Mexico

MEA

• Saudi Arabia
• United Arab Emirates
• South Africa

List of Companies

• Johnson & Johnson
• AbbVie
• Merck & Co.
• Bristol Myers Squibb
• Novartis
• Amgen
• Sanofi
• Pfizer
• Eli Lilly and Company
• AstraZeneca